MedTrace Logo

Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery

NCT06092671 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 444

Last updated 2025-12-29

No results posted yet for this study

Summary

Emergence delirium (ED) stands out as a prevalent postoperative complication among paediatric patients, correlating with extended hospitalization periods, escalated healthcare expenses, and increased incidence of postoperative maladaptive behaviours (POMBs). There is a lack of well-established pharmacological or non-pharmacological interventions demonstrating efficacy in reducing the occurrence of ED. Therefore, our objective is to assess the potential of family-centred perioperative care for anaesthesia (FPCA) in mitigating the incidence of ED in children, compared with routine anaesthesia.

Conditions

  • Postoperative Complications
  • Child
  • Family
  • Emergence Delirium
  • General Anaesthesia
  • Perioperative Care

Interventions

OTHER

Family-centred perioperative care for anaesthesia

The patient in intervention group and parent will receive the Family-centred perioperative care for anaesthesia, including video education, anaesthesia mask practice, electronic pamphlet,etc. It is recommended that parents accompany the children during the induction of anesthesia and the recovery from anesthesia.

Sponsors & Collaborators

  • Jinhua Municipal Central Hospital

    collaborator OTHER

  • Lishui Country People's Hospital

    collaborator OTHER

  • Ningbo No.2 Hospital

    collaborator OTHER

  • The Central Hospital of Lishui City

    collaborator OTHER

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Ting Li, MD. PhD · Department of Anaesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-24
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06092671 on ClinicalTrials.gov